Search

everythinglearnresearchcommunity

for

Search:↓

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Two patients had a rare combination of red skin spots and white scaly skin lesions not on the genitals.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Platelet-Rich Plasma (PRP) shows promise for treating various skin conditions, but more research is needed to standardize its use.

Platelet-rich plasma shows potential for hair growth, but more research is needed to determine the best preparation method.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

The method reliably profiles eicosanoids and shows epitestosterone reduces their levels, similar to common anti-inflammatory drugs.

Men with both baldness and scalp psoriasis often don't have psoriasis on bald spots.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

PDRN, derived from salmon sperm, shows promise in healing wounds, reducing inflammation, and regenerating tissues, but more research is needed to understand its mechanisms and improve its use.

Using a 308-nm excimer lamp with minoxidil promotes hair growth in Alopecia Areata patients, especially younger ones or those with smaller bald spots.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Alopecia areata in Taif is common, mainly immune-related, and best treated with topical corticosteroids and vitamins.

Scalp sarcoidosis can cause hair loss and needs accurate diagnosis and treatment with specific medications.

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.

PRP shows promise for treating hair loss but needs standardized methods to confirm its effectiveness.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

A woman with dermatomyositis showed rare skin symptoms, was treated successfully, and her case suggests checking for cancer in similar patients.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Scalp Roller therapy helped improve hair growth in patients with hard-to-treat alopecia areata.

Sunlight exposure improved a patient's skin condition, and there may be a link between a certain disease and skin growths; a leukemia treatment caused changes in hair color and growth.

A woman with a rare type of dermatomyositis improved with low-dose prednisone and methotrexate.

The document concludes that accurate diagnosis of alopecia in children relies on thorough examination and history, and while treatments exist, none can alter the course of alopecia areata, which can significantly affect a child's psychological well-being.